Patent clarity for life-changing innovations.
From small molecule drugs and biologics to gene therapies, monoclonal antibodies, and advanced biotech platforms, the pharma and biotechnology industry is driven by high-stakes intellectual property. We help pharmaceutical companies, biotech firms, and CDMOs protect, clear, and monetize their innovations across major global markets.
IP challenges in Pharma & Biotechnology
The pharmaceutical and biotechnology sectors are among the most patent-intensive industries. New drug candidates, novel biologics, gene therapies, cell therapies, and advanced manufacturing processes are protected by complex patent portfolios covering composition of matter, methods of use, formulations, manufacturing processes, and second-generation innovations.
With patent cliffs approaching for many blockbuster drugs, biosimilar competition rising, and increasing regulatory scrutiny, companies must carefully manage their IP portfolios. Issues such as patent term extensions (PTE), Supplementary Protection Certificates (SPC), evergreening strategies, and varying global patent eligibility standards add further complexity.
Whether you are developing a new molecular entity, advancing a novel biologic platform, or preparing for biosimilar entry, early and thorough patent analysis is critical to secure market exclusivity and avoid expensive litigation.
How we support Pharma Biotech IP programs
Scientific expertise combined with sophisticated global patent strategy tailored to pharmaceuticals and biotechnology.
Technical Disclosure & NDA Execution
We begin with a binding NDA and collect detailed scientific data on your compound, biologic, process, or platform technology.
Technology & Jurisdiction Mapping
We map your innovation across key patent categories and regulatory markets with focus on patent term extensions.
Patent Landscape & FTO Search
Comprehensive searches covering composition, method of treatment, formulation, manufacturing, and polymorph patents.
Claim-Level Risk Analysis
Our PhD-level scientists and patent attorneys perform detailed element-by-element claim mapping.
Report & Strategic Recommendations
You receive an actionable report including risk assessment, design-around strategies, portfolio optimization, and regulatory/IP alignment.
What you receive
Why Pharma Biotech companies need strong IP strategy
With development costs often exceeding $1–2 billion per drug and long regulatory timelines, robust patent protection is essential to recoup investments and maintain market exclusivity. Effective IP strategy directly impacts company valuation, partnership opportunities, and competitive positioning.
Frequently asked questions
Because of extremely high R&D costs and long development timelines, patents provide the market exclusivity needed to recover investments and generate returns.
Yes. We provide full-spectrum support including freedom-to-operate searches, patentability analysis, landscape studies, and strategic portfolio development.
Small molecules, biologics, biosimilars, gene & cell therapy, mRNA, CRISPR, immuno-oncology, and advanced drug delivery systems.
Most projects are completed within 7–14 business days depending on scope and number of jurisdictions.
Yes. All work begins with a binding NDA and follows strict confidentiality protocols.
Ready to assess your pharma & biotech IP position?
Get a thorough patent and IP analysis from technical experts with deep pharmaceutical and biotechnology domain experience — delivered in 5–7 business days.